• Correct treatment of sheep scab involves treatment of all in-contact sheep and strict separation of treated and untreated sheep.
• If an outbreak of sheep scab is confirmed and treatment correctly performed, consider investigation of apparent treatment failure as resistance to injectable macrocyclic lactones has now been reported, • Control of sheep scab should focus on strict biosecurity measures and cooperation among flocks to treat at the same time.
• Better use of the available diagnostic techniques can reduce reliance on therapeutic drugs.
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collected from four farms with reported treatment failure were exposed to different concentrations of the compound, they were able to demonstrate that these mites could survive even when exposed to a very high concentration of the compound (100 times higher than the expected plasma concentration). 4 The implications of this report are important, although the appearance of resistance to acaricidal drugs may not have come as a surprise. As we have learned too well from the development of antimicrobial resistance, it is only a matter of time before an organism repeatedly exposed to the same therapeutic drug will develop resistance, as selective pressure is facilitated by exposing the organisms to the same compound over time. Furthermore, as Doherty and others state in their article, the development of cross-resistance to other macrocyclic lactone compounds is a potential possibility. If this is the case, there will be major limitations in the use of these compounds to treat sheep scab in the future.
Among farmers, the use of injectable macrocyclic lactone is still predominant 5 as these drugs have major benefits over the use of organophosphate dips, being more operator-friendly and easier to administer and dispose of. 6 They are also the only choice available in the case of heavily pregnant sheep, where it would not be recommendable to submerge sheep at an advanced stage of gestation.
SHEEP scab is a parasitic allergic dermatitis that affects sheep worldwide and is caused by the nonburrowing mite, Psoroptes ovis. It has serious welfare implications for animals affected (Fig 1) and a huge economic impact on the sheep farming industry. The disease is estimated to cost the UK sheep industry £8 million annually, with prevention accounting largely for this figure. 1 As with any other contagious disease, prevention should really focus on strict biosecurity, mainly through quarantine (and possibly treatment) of all incoming animals on to a farm. Prophylactic treatments have been advocated as a cost-effective strategy, although only when there is a high risk of infection and mainly for upland farmers. 2 At present, two classes of antiparasitic drugs are licensed in the UK for treatment and control of sheep scab. These are the organophosphate dip diazinon and the injectable macrocyclic lactones. The choice of drug class used is usually influenced by a number of factors, such as labour requirements, flock type and size, time of the year and control of other ectoparasitic diseases. 3 Irrespective of the drug chosen, it is of paramount importance that the treatment is carried out properly (Fig 2) and the compound is effective at killing all of the mites. In a study summarised on p 106 of this week's issue of Vet Record, Doherty and others confirmed the first evidence of resistance to moxidectin, an injectable macrocyclic lactone that can be used for both prevention and treatment of sheep scab. Using a laboratory assay in which mites An additional complication comes from the fact that injectable macrocyclic lactones are also among the most commonly used drugs for nematode control. 7 Knowing that anthelmintic resistance is now a widespread problem, 8 we ought to start questioning if our control strategies are appropriate. In light of these problems, indiscriminate prophylactic treatments should not be recommended. On the contrary, an approach based on the wider use of diagnostics should be advocated. It would be appropriate to make better use of the recently developed serum ELISA test for diagnosis of sheep scab 9 to incoming animals on a farm, as part of biosecurity measures, to look for evidence of exposure to the disease and to avoid the unnecessary treatment of unaffected animals.
Finally, a genuine collaboration between farmers, vets and the industry is also needed for effective control of this disease. The risk of introducing sheep scab into a flock is increased by up to 10-fold when confirmed cases of the disease are diagnosed in a neighbouring flock or in cases where common grazing is used. 10 This reiterates that treating a sheep scab outbreak as a single entity will not allow for real control of the disease. Efforts should instead be put towards coordination, both at regional and national levels, to make sure that not only all animals are properly treated, but neighbouring farms are aware of the situation and the likely source of infestation can be identified. Also, based on the report by Doherty and others, 4 all cases of suspected treatment failure should prompt further investigation to prevent potentially resistance mites from infecting other farms and become more widely established.
